What is NCT05512345 (phentolamine mesylate) testing?
I can’t reliably identify what specific study NCT05512345 is doing from the information available in this chat. Trial registry details like the phase, condition, intervention dose, locations, and primary endpoints come from the trial record itself, and I don’t have access to that record here.
How can you find the exact trial details for NCT05512345?
If you open the trial listing on ClinicalTrials.gov for NCT05512345, you’ll see the full protocol summary, including:
- Condition/disease being studied
- Study phase (e.g., Phase 1/2/3)
- Trial design (randomized, blinded, placebo-controlled, etc.)
- Dosing regimen and route for phentolamine mesylate
- Primary and secondary outcome measures
- Recruitment status and expected completion dates
- Study locations and eligibility criteria
What questions people usually check for phentolamine mesylate trials
Depending on the condition, searchers commonly want to know:
- Whether it’s being tested for acute vascular/spasm-related problems, erectile dysfunction, or another indication
- Safety profile (e.g., blood-pressure effects)
- Whether it’s an oral, topical, or injection formulation and how that affects monitoring
- Whether results are posted (and whether they’re actively recruiting or completed)
If you paste the registry text, I can summarize it tightly
Share the ClinicalTrials.gov fields you see (or paste the “Brief Summary,” “Interventions,” “Outcomes,” and “Eligibility Criteria” sections). Then I can produce a clean, journal-style summary focused on:
- What phentolamine mesylate is being tested for
- Who qualifies
- What outcomes are measured
- Trial status and timeline cues
- Any notable safety/monitoring details
Sources
No sources were cited because the NCT05512345 registry record content was not provided in the prompt.